主 办:北 京 中 医 药 大 学
ISSN 1006-2157 CN 11-3574/R

北京中医药大学学报 ›› 2020, Vol. 43 ›› Issue (5): 363-367.doi: 10.3969/j.issn.1006-2157.2020.05.002

• 新冠肺炎专题 • 上一篇    下一篇

新型冠状病毒肺炎恢复期的中医药干预策略*

杨先照1, 杜宏波1, 赫伟丽1, 张敬锋2, 刘宁1, 崔杰2, 陈正光1, 杜勇2, 叶永安1#   

  1. 1.北京中医药大学东直门医院 北京 100700;
    2.北京中医药大学东方医院
  • 收稿日期:2020-03-02 发布日期:2020-06-08
  • 通讯作者: #叶永安,男,博士,教授,主任医师,博士生导师,主要研究方向:慢性传染病的中西医临床与基础研究,E-mail: yeyongan@vip.163.com
  • 作者简介:杨先照,男,博士,副主任医师,硕士生导师
  • 基金资助:
    *北京中医药大学东直门医院第三批“青苗人才”项目( No.DZMYS-201809)

Traditional Chinese medical strategy in the management of the corona virus disease 2019 during recovery period*

Yang Xianzhao1, Du Hongbo1, He Weili1, Zhang Jingfeng2, Liu Ning1, Cui Jie2, Chen Zhengguang1, Du Yong2, Ye Yong’an1#   

  1. 1. Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China;
    2. Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China
  • Received:2020-03-02 Published:2020-06-08
  • Contact: Prof. Ye Yong’an,MD, Chief Physician, Doctoral Supervisor, Dongzhimen Hospital, Beijing University of Chinese Medicine. Dongcheng District, Hai Yun Cang on the 5th Zip, Beijing 100700. E-mail: yeyongan@vip.163.com
  • Supported by:
    The Young Scientist Development Program of Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (No. DZMYS-201809)

摘要: 目前新型冠状病毒肺炎整体疫情得到有效控制,治愈出院病例已超过现有确诊病例。虽然出院患者的病情均得到一定程度的改善,但相当部分患者仍然存在临床不适以及器官损伤问题,因而后续的康复治疗显得十分重要。本团队赴武汉疫区积极开展了中医药临床救治,发现本病病程相对偏长,在本病的恢复期肺纤维化的问题较为突出。新冠肺炎恢复期患者多处于以气虚为主证,而血瘀之象逐渐凸显,兼余邪未净的复杂状态。基于实地观察,我们认为气虚血瘀是其核心病机。因而新冠肺炎恢复期患者的治疗,应针对肺纤维化这一关键病理环节,以益气活血为基本法则,同时兼顾清解余邪,灵活加减用药,达到患者良好康复的目标。

关键词: 新型冠状病毒肺炎, 恢复期, 中医药, 干预策略

Abstract: It has been more than two months since the outbreak of Corona Virus Disease 2019 (COVID-19), and the overall epidemic situation is now under effective control with the number of cured discharged cases surpassing existing confirmed ones. Although the general condition of discharged patients has been improved to a certain extent, quite a number of them still have clinical symptoms and organ injury. Therefore, follow-up rehabilitation treatment for these patients is of great importance. Our team went to Wuhan, the center of epidemic regions, to assist clinical treatment using traditional Chinese medicine. From our experience, we found the course of the disease is relatively long, and that the problem of pulmonary fibrosis is more prominent during the recovery period. Most COVID-19 patients at the recovery stage tend to present with a complicated state of multiple patterns, characterized by dominant qi deficiency, increasing severity of blood stasis together with remaining excess of pathogens. Based on field observations, we hold that the qi deficiency and blood stasis is the core pathogenesis. Therefore, management of COVID-19 patients during the recovery period should target at pulmonary fibrosis as the key pathology by using qi-tonifying blood-activating treatment as the basic principle, combined with methods of clearing away the remaining pathogenic factors. Flexible medicinal modification could help patients recover better.

Key words: COVID-19, recovery period, traditional Chinese medicine, prevention and preatment strategy

中图分类号: 

  • R254.3